ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "diagnosis"

  • Abstract Number: 134 • 2020 Pediatric Rheumatology Symposium

    Evaluation of Self-report Screening Measures in the Detection of Depressive and Anxiety Disorders Among Children and Adolescents with Systemic Lupus Erythematosus

    Michelle Quilter1, Katherine Cost 2, Reva Schachter 3, Julie Couture 4, Ashley Danguecan 5, Lawrence Ng 6, Daniela Dominguez 6, Linda Hiraki 7, Deborah Levy 8, Earl D. Silverman 9, Kate Neufeld 10, Andrea Knight 11 and Daphne Korczak 2, 1Dept. of Psychiatry, Hospital for Sick Children, Dept. of Psychiatry, University of Toronto, Toronto, Ontario, Canada, 2Dept. of Psychiatry, Hospital for Sick Children, Dept. of Psychiatry, University of Toronto, Toronto, Canada, 3Dept. of Psychiatry, Hospital for Sick Children,, Toronto, Canada, 4Division of Pediatric Rheumatology-Immunology, CHU Sainte-Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada, 5Hospital for Sick Children, Toronto, Canada, 6Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada, 7Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Canada, 8Division of Rheumatology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Canada, 9Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 10University of Toronto, The Hospital for Sick Children, Toronto, Canada, 11SickKids Research Institute, Toronto, Canada

    Background/Purpose: Screening for co-morbid psychiatric disorder is of high clinical importance in childhood-onset systemic lupus erythematosus (cSLE). However, there are no validated screening measures for…
  • Abstract Number: 2074 • 2019 ACR/ARP Annual Meeting

    Automated Diagnosis Extraction from Electronic Medical Records with Machine Learning Classifiers

    Tjardo Maarseveen1, Thomas Huizinga 1, Marcel J.T. Reinders 1, Erik van den Akker 1 and Rachel Knevel 1, 1Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The use of Electronic Medical Records (EMR) for research purposes has led to an increasing interest in Natural Language Processing (NLP) for text classification.…
  • Abstract Number: 2655 • 2019 ACR/ARP Annual Meeting

    Large Vessel Vasculitis: Diagnosis Is Very Frequent with Ultrasound Examination and Shows Responsiveness to Treatment

    Eugenio de Miguel1, Irene Monjo 2, Elisa Fernández 3, Diana Peiteado 4, Chamaida Plasencia 5 and Alejandro Balsa 5, 1Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, 2FIBHULP-IdiPAZ-Hospital La Paz-Rheumatology, Madrid, Spain, 3Rheumatology Department, La Paz University Hospital, Madrid, Madrid, Spain, 4Hospital Universitario La Paz, Madrid, 5Immuno-Rheumatology Research Group, IdiPaz & Rheumatology Department. La Paz University Hospital, Madrid, Spain

    Background/Purpose: Giant cell arteritis (GCA) is the most common systemic vasculitis in the elderly. In the EULAR recommendations of 2018 for the use of imaging…
  • Abstract Number: 2763 • 2019 ACR/ARP Annual Meeting

    What Disease Do You Have? – Assessment and Predictors of Accurate Illness Naming in Rheumatology

    Jacob Meindertsma1, Kara Harrison 1, Nicholas Lucchesi 1 and Adam Carlson 1, 1University of Virginia, Charlottesville, VA

    Background/Purpose: Shared decision making remains central to the effective treatment of many rheumatologic conditions and is most appropriate when the patient and physician agree on…
  • Abstract Number: 465 • 2019 ACR/ARP Annual Meeting

    Prognostic Factors and Clinical Outcome Modifiers in Patients with Rheumatoid Arthritis: A Review

    Leticia Ferri1, Grace Crocket 2, Xue Han 1, Boris Breznen 3 and Mir Sohail Fazeli 3, 1Bristol-Myers Squibb Company, Princeton, NJ, 2Bristol-Myers Squibb; Rutgers University, New York City, NY, 3Doctor Evidence, Santa Monica, CA

    Background/Purpose: The current goal in treatment of RA is to deliver therapies tailored to individual patients’ characteristics. Establishing disease prognosis is a crucial first step…
  • Abstract Number: 488 • 2019 ACR/ARP Annual Meeting

    Citrullinated Antigens with Multiple Citruline Similar Motif Could Be Used for RA Diagnosis

    zhiwei ru 1, Xuedong Chen 2, Xiaoyan huang 1, Jianrong Lou 1, YongZheng peng 3 and Xiang Yang1, 1Leide bioscience Inc, guang zhou, Guangdong, China (People's Republic), 2Southern Medicine University, guang zhou, Guangdong, China (People's Republic), 3Southern Medicine University, guang dong, Guangdong, China (People's Republic)

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic joint inflammation that ultimately leads to joint destruction. Diagnosis of RA is important…
  • Abstract Number: 1049 • 2018 ACR/ARHP Annual Meeting

    Optical Biomarkers for the Early Diagnosis of Osteoarthritis

    Paula Casal Beiroa1,2, Elena F. Burguera2,3,4, Tamara Hermida-Gómez2,3,4, Noa Goyanes5, Natividad Oreiro4,6, Pío González7, Francisco J Blanco8 and Joana Magalhaes2,4,9, 1Unidad de Medicina Regenerativa. Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC). CHUAC. SERGAS., A Coruña, Spain, 2Centro de Investigaciones Científicas Avanzadas (CICA), Universidad de A Coruña (UDC)., a coruña, Spain, 3Unidad de Medicina Regenerativa, Grupo de Investigación en Reumatología, Agrupación Estratégica CICA-INIBIC, Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), A Coruña, Spain, 4Centro de Investigación Biomédica en Red (CIBER), madrid, Spain, 5Centro de Investigaciones Científicas Avanzadas (CICA), Universidad de A Coruña (UDC)., A Coruña, Spain, 6Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña. España, A Coruna, Spain, 7Grupo de Nuevos Materiales. Departamento de Física Aplicada. Universidad de Vigo., Vigo, Spain, 8Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Universidade de A Coruña (UDC), A Coruña, Spain, 9Unidad de Medicina Regenerativa. Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC). CHUAC. SERGAS., a coruña, Spain

    Background/Purpose: Osteoarthritis (OA) is a rheumatic disease characterized by articular cartilage degradation. On its early stages, OA is asymptomatic and its current gold-standard diagnosis (X-Rays),…
  • Abstract Number: 1236 • 2018 ACR/ARHP Annual Meeting

    Peripheral-Blood B-Cell Subset Disturbances in Whipple’s Disease

    Maelle Le Goff1, Divi Cornec2, Dewi Guellec1, Thierry Marhadour1, Valérie Devauchelle-Pensec1, Sandrine Jousse-Joulin1, Marion Herbette1, Jean-Michel Cauvin3, Clara Le Guillou3, Yves Renaudineau4, Jacques-Olivier Pers5 and Alain Saraux1, 1Rheumatology, CHU Brest, Brest, France, 2Rheumatology and UMR1227, Lymphocytes B et Autoimmunité, CHU Brest, Brest, France, 3CDC, CHU Brest, Brest, France, 4U1227, Université de Brest, inserm, Labex IGO, CHU de brest, Brest, France, 5U1227, Université de Brest, Inserm, Labex IGO, CHU de Brest, Brest, France

    Background/Purpose: Whipple’s disease (WD) is a rare, systemic, disease caused by the intracellular Gram-positive bacterium Tropheryma whipplei (TW). This ubiquitous commensal organism is transmitted among…
  • Abstract Number: 1442 • 2018 ACR/ARHP Annual Meeting

    Differential Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry and a Universal Metabolome Standard Reveals a Metabolome Profile with Consistent Accuracy for Rheumatoid Arthritis

    Walter P. Maksymowych1, Xiaohang Wang2, Joel Paschke1, Rana Dadashova1, Edna Hutchings1 and Liang Li2, 1CaRE Arthritis, Edmonton, AB, Canada, 2Chemistry, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Early diagnosis of rheumatoid arthritis (RA) is hampered by suboptimal accuracy of currently available serological biomarkers. Recent advancements in metabolomic profiling include dansylation liquid…
  • Abstract Number: 1444 • 2018 ACR/ARHP Annual Meeting

    Optimization of Ultrasonographic Examination for the Diagnosis of Erosive Rheumatoid Arthritis Versus Erosive Osteoarthritis with Radiography Considered As Gold Standard

    Camille Roux1, Frédérique Gandjbakhch2, Audrey Pierreisnard3, Marion Couderc4, Cédric Lukas5, Racha Masri1, Jean-Philippe Sommier1, Isabelle Clerc-Urmès6, Cedric Baumann7, Isabelle Chary-Valckenaere8 and Damien Loeuille1, 1Rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 2UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France, 3APHP, Paris, France, 4Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 5Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France, 6CHRU Nancy, Nancy, France, 7CHRU Nancy, Vandoeuvre les Nancy, France, 8Rheumatology, CHRU Nancy, Vandoeuvres les Nancy, France

    Background/Purpose: Rheumatoid arthritis (RA) is the most prevalent chronic inflammatory joint disease (1,2) responsible for structural damage. Radiography (RX) is considered as the gold standard…
  • Abstract Number: 1452 • 2018 ACR/ARHP Annual Meeting

    Combination of Ultrasound Power Doppler-Verified Synovitis and Seropositivity Accurately Identifies Patients with Early Rheumatoid Arthritis

    Shinya Kawashiri1, Keita Fujikawa2, Ayako Nishino1, Ayuko Takatani1, Toshimasa Shimizu1, Masataka Umeda1, Shoichi Fukui1, Takashi Igawa1, Tomohiro Koga1, Naoki Iwamoto1, Kunihiro Ichinose1, Mami Tamai1, Hideki Nakamura1, Tomoki Origuchi3 and Atsushi Kawakami1, 1Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Japan Community Health care Organization Isahaya General Hospital, Nagasaki, Japan, 3Department of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    Background/Purpose: We conducted this retrospective study to determine objective and comprehensive diagnostic criteria for early rheumatoid arthritis (RA) that are based on ultrasound (US) and…
  • Abstract Number: 1467 • 2018 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Activity Monitoring and Multiplex Biomarker Verification By Tageted Proteomics

    Lucía González-Rodríguez1, Valentina Calamia1, Patricia Fernández2, Cristina Ruiz-Romero3, Antonio Julià4, Antonio Fernández-Nebro5, Jesús Tornero6, Sara Marsal4 and Francisco J Blanco3, 1Proteomics Group, Rheumatology Division, ProteoRed, PRB2-ISCIII. INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 2Proteomics group, Rheumatology Division, ProteoRed, PRB2-ISCIII. INIBIC-Hospital Universitario A Coruña, La Coruña, Spain, 3Rheumatology Division, ProteoRed, PRB2-ISCIII. INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 4Rheumatology Research Group, Vall d’Hebron Hospital Research Institute, Barcelona, Spain., Barcelona, Spain, 5UGC Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Spain., Málaga, Spain, 6Hospital Universitario Guadalajara, Guadalajara, Spain., Guadalajara, Spain

    Background/Purpose: Rheumatoid arthritis (RA) is a long-lasting inflammatory autoimmune disorder that ultimately leads to the destruction of joint architecture. The activity of this disease is…
  • Abstract Number: 1477 • 2018 ACR/ARHP Annual Meeting

    Serum Autoantibody Multi-Analyte Testing in Rheumatoid Arthritis Can Reduce Avoidable Costs Associated from False Positive Results. a Simulation Study in the United States of America

    Barbara Mascialino1, Sascha Swiniarski2, Isabel Gehring3, Maryam Poorafshar1 and Teresa Tarrant4, 1Thermo Fisher Scientific, Uppsala, Sweden, Uppsala, Sweden, 2Thermo Fisher Scientific, Freiburg, Germany, Freiburg, Germany, 3Thermo Fisher Scientific, Freiburg, Germany, 4Division of Rheumatology and Immunology, Duke School of Medicine, Durham, NC

    Serum Autoantibody Multi-Analyte Testing in Rheumatoid Arthritis Can Reduce Avoidable Costs Associated from False Positive Results. A Simulation Study in the United States of AmericaBarbara…
  • Abstract Number: 1650 • 2018 ACR/ARHP Annual Meeting

    Subclinical Atheromatosis and Estimation of Cardiovascular Risk in Patients with Axial Spondyloarthritis

    Tomas Cazenave1, Maria Celeste Orozco2, Gustavo Citera3, Emilce E Schneeberger1 and Marcos G. Rosemffet2, 1Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 3Rheumatology Section, Instituto de Rehabilitación Psicofísica, CABA, Argentina

    Background/Purpose: There is evidence that shows an increased cardiovascular risk in patients with Axial Spondyloarthritis (axSpA). Ultrasonography (US) is a simple imaging tool used to…
  • Abstract Number: 186 • 2018 ACR/ARHP Annual Meeting

    The Accuracy and Potential Impact of a Diagnostic Decision Support System in Rare Disease Cases

    Simon Ronicke1,2, Martin C. Hirsch3, Ewelina Türk3, Katharina Larionov2, Daphne Tientcheu2 and Annette D. Wagner2, 1Ada Health GmbH, Belrin, Germany, 2Nephrology, Medical School Hannover, Hannover, Germany, 3Ada Health GmbH, Berlin, Germany

    Background/Purpose: Diagnosis in rare diseases cases is often delayed by several years. Main factors for delayed diagnosis are believed to be lack of awareness and…
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology